Mr Robert Charles Cutter, RPH | |
1500 Division St, Oregon City, OR 97045-1527 | |
(503) 518-3251 | |
Not Available |
Full Name | Mr Robert Charles Cutter |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 1500 Division St, Oregon City, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255320107 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 8677 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Robert Charles Cutter, RPH 13183 Millenium Way, Oregon City, OR 97045-6701 Ph: (503) 657-6718 | Mr Robert Charles Cutter, RPH 1500 Division St, Oregon City, OR 97045-1527 Ph: (503) 518-3251 |
News Archive
Boehringer Ingelheim is a group of companies dedicated to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. It is one of the world's 20 leading pharmaceutical companies. Boehringer Ingelheim's business areas include Prescription Medicines, Consumer Health Care and Biopharmaceuticals, as well as Pharma Chemicals and Animal Health.
Stimatix GI, located in the Misgav Venture Accelerator, has reported encouraging interim results in its animal trials of the AOS-C1000 artificial sphincter, designed to provide stoma patients with a new means of bowel control.
The very same treatment that thwarts breast cancer has a dark side – it can fuel the spread of the disease to the lungs.
GeneLink, Inc., has appointed Jim Monton to the Company's Board of Directors. Mr. Monton brings decades of product development and branding experience, both domestic and international, in health and beauty care for Procter & Gamble (P&G). Jim will serve on the Audit and Compensation Committees of the Board of Directors.
Today Biogen Idec and Elan Corporation, plc announced that they have submitted applications to the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) requesting updates to the TYSABRI (natalizumab) labels.
› Verified 5 days ago
Christopher Merkle, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1900 Mcloughlin Blvd, Oregon City, OR 97045 Phone: 503-656-1020 | |
Emad Abukhzam, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 19007 Beavercreek Rd, Oregon City, OR 97045 Phone: 503-657-3191 | |
Andrew L Waldal, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 998 Library Ct Rm 4, Oregon City, OR 97045 Phone: 503-557-3051 Fax: 503-557-3052 | |
Mrs. D Renee Lewis, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 358 Warner Milne Rd Ste G-103, Oregon City, OR 97045 Phone: 503-655-1221 Fax: 503-305-2105 | |
Kevin M Tam, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1900 Mcloughlin Blvd Ste 22, Oregon City, OR 97045 Phone: 503-656-1020 | |
Dr. Vincent Hatakeyama, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1900 Mcloughlin Blvd, Oregon City, OR 97045 Phone: 503-656-1020 | |
Christy Evelyn Svendsen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1839 Molalla Ave, Oregon City, OR 97045 Phone: 503-657-1483 |